Overview of Psychedelic Mushroom Initiatives
Friends,
Sean McAllister has expanded his groundbreaking work from cannabis to include the emerging issues around psychedelic mushrooms or psilocybin. Sean is General Counsel to the Denver campaign that decriminalized psilocybin mushrooms last year and he has been appointed by the Mayor of Denver to the Psilocybin Mushroom Policy Review Panel working on the implementation of the law. In addition, Sean is now General Counsel to the Chacruna Institute for Psychedelic Plant Medicine. In this emerging field, there may be regulated business allowed as a result of state ballot initiatives in November 2020 in California, Oregon, and possibly Colorado. Sean has summarized the current decriminalization laws in Denver and Oakland, and reviewed the proposed ballot initiatives in California and Oregon in this article:
Sean will be speaking on this topic at the Psychedelic Liberty Summit in San Francisco in April.
Psychedelic Liberty Summit Information
If you are interested in discussing this topic, contact Sean to set up a consultation.
Related Article
Emerging Trends In Psychedelic Laws: Implications for Practitioners
As the psychedelic renaissance continues, legal landscapes globally are evolving rapidly. What was once a fringe area of medical research and therapy is now moving towards mainstream acceptance, driven by promising results in clinical trials and changing public perceptions. For practitioners, these shifts present both exciting opportunities and complex challenges. This blog post explores emerging […]
McAllister Law Office – Psychedelic Law Update – June 2024
1. With Sean McAllister as one of their lawyers, The Church of The Eagle and The Condor is recognized as the third religious organization authorized to use ayahuasca in the United States. In a career highlight, I was honored to one of five lawyers representing The Church of The Eagle and The Condor (“CEC”) in […]
Navigating New Realms: The Crucial Role Of Legal Guidance In Psychedelic Business Start-Ups
In recent years, the interest in psychedelics for therapeutic purposes has surged, offering a promising frontier in both medical science and entrepreneurship. However, the burgeoning field of psychedelic businesses also presents a unique set of legal challenges. For start-ups in this industry, navigating the complex regulatory environment is not just about compliance, but also about […]